ÂÜÀòÂÒÂ×

Andrew Morrell is a seasoned research chemist currently employed at KalVista Pharmaceuticals, Inc. since September 2021. Prior to this role, Andrew served as an Experimental Officer in Analytical Services at the University of Kent, where responsibilities included managing analytical services to support teaching and research activities. Andrew has extensive experience in the pharmaceutical industry, having worked as a Chemist at Pfizer, focusing on sustainable catalytic methods and high-throughput screening, and previously at Peakdale Molecular, where synthesis and characterization of pharmaceutical compounds were primary tasks. Notable prior experience also includes a Principal Scientist position at Pfizer, advancing medicinal chemistry through automated synthesis, and leading pharmaceutical R&D at Warner Lambert, notably in neuropeptide research. Academic credentials include a PhD in Chemistry from The University of Manchester, supplemented by a Master of Science degree from the same institution.